Evoke Pharma, Inc. (formerlyNASDAQ: EVOK) (“Evoke”) and QOL Medical, LLC (“QOL Medical”) announce that the tender offer (the “Offer”) by QOL-EOS Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of QOL Medical (the “Merger Sub”), to acquire all of the outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of Evoke, in exchange for $11.00 in cash per share (the “Offer Price”), subject to any applicable withholding and without interest thereon, expired at one minute past 11:59 p.m., New York City Time, on December 15, 2025 (the “Expiration Time”) and was not extended. Following the consummation of the Offer, Merger Sub merged with and into Evoke (the “Merger”).
Read the full article: Evoke Pharma and QOL Medical Announce Expiration of Tender Offer //
Source: https://www.prnewswire.com/news-releases/evoke-pharma-and-qol-medical-announce-expiration-of-tender-offer-302644883.html